AbCellera Biologics Inc. (ABCL) shares outstanding

Shares outstanding · fiscal 2025
298.71M

AbCellera Biologics Inc. (ABCL) had 298.71M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.5% higher than the 294.33M of fiscal 2024. Figures as of 18 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
298.71M
Change on fiscal 2024
+1.5%
Growth, 5 years
+2.6% a year
Highest on record
318.29Mfiscal 2021
Lowest on record
151.33Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

AbCellera Biologics Inc. shares outstanding, in more detail

The market data feed counts 326.62M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.6% a year. Across the 7 fiscal years on record (2019–2025), the highest was 318.29M in fiscal 2021 and the lowest 151.33M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

AbCellera Biologics Inc. shares outstanding, year by year

AbCellera Biologics Inc. (ABCL) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025298.71M 1.5% up
2024294.33M 1.8% up
2023289.17M 8.2% down
2022314.83M 1.1% down
2021318.29M 21.0% up
2020263.13M 73.9% up
2019151.33M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on ABCL

AbCellera Biologics Inc., figure by figure

AbCellera Biologics Inc. (ABCL) overview: price, valuation and scorecard

AbCellera Biologics Inc. shares outstanding: questions and answers

How many shares does AbCellera Biologics Inc. have?

AbCellera Biologics Inc. (ABCL) had 298.71M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.5% higher than the 294.33M of fiscal 2024. The market data feed counts 326.62M shares outstanding today.

What is the growth rate of AbCellera Biologics Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.6% a year.

What are the highest and lowest diluted share count figures on record for AbCellera Biologics Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was 318.29M in fiscal 2021 and the lowest 151.33M in fiscal 2019.

How is AbCellera Biologics Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For AbCellera Biologics Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AbCellera Biologics Inc. (ABCL) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ABCL/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.